The Series A round, which included participation from North Island Ventures and existing investors, brings New York-based Mural's total funding to $28 million.
OpenAI is acquiring startup Orchestra Bio and plans to merge it with its life sciences AI platform Rosalind. The goal is to build AI agents that help pharma teams coordinate drug development, from tracking trials to spotting problems. Developing a new drug in the US takes ten to 15 years on average. OpenAI already works with Novo Nordisk and Moderna on AI-driven pharma research.
Enterprises are deploying AI agents on top of incomplete and siloed workforce data that sit scattered across HR and finance systems and a decade of point solutions, each with its own definitions and blind spots.
Some of the most interesting moments in music production come when an arrangement won’t work. The groove is there and the melody is promising, but something
A panel's human-equivalent size is target-specific. Matching a fixed 32-judge panel to empirical human label distributions on three ChaosNLI tasks yields two distinct effective sizes: distributional-error matching gives $ν_{\mathrm{MSE}}=2.304$, $3.750$, and $3.445$, whereas…
In automated Printed Circuit Board Assembly (PCBA) inspection, standards-guided decisions require systems to jointly reason over fine-grained visual cues, component semantics, and manufacturing knowledge. Although large vision-language models (VLMs) provide a promising…
Text-guided video editing modifies target content while preserving the appearance and temporal coherence of unedited regions. Training-based approaches provide strong control but demand substantial data and computation. Training-free methods fall into inversion-free and…
Production LLM agents are evaluated repeatedly as they evolve, but full agent benchmarks are costly to rerun. We study efficient recurring evaluation for a production analytics agent serving tens of thousands of monthly active users and report first-hand deployment experience.…